Direkt zum Inhalt
Merck
  • Novel hypoglycemic injury mechanism: N-methyl-D-aspartate receptor-mediated white matter damage.

Novel hypoglycemic injury mechanism: N-methyl-D-aspartate receptor-mediated white matter damage.

Annals of neurology (2013-11-19)
Xin Yang, Margaret A Hamner, Angus M Brown, Richard D Evans, Zu-Cheng Ye, Shengdi Chen, Bruce R Ransom
ZUSAMMENFASSUNG

Hypoglycemia is a common adverse event and can injure central nervous system (CNS) white matter (WM). We determined whether glutamate receptors were involved in hypoglycemic WM injury. Mouse optic nerves (MON), CNS WM tracts, were maintained at 37°C with oxygenated artificial cerebrospinal fluid (ACSF) containing 10mM glucose. Aglycemia was produced by switching to 0 glucose ACSF. Supramaximal compound action potentials (CAPs) were elicited using suction electrodes, and axon function was quantified as the area under the CAP. Amino acid release was measured using high-performance liquid chromatography. Extracellular lactate concentration ([lactate(-)]o) was measured using an enzyme electrode. About 50% of MON axons were injured after 60 minutes of aglycemia (90% after 90 minutes); injury extent was not affected by animal age. Blockade of N-methyl-D-aspartate (NMDA)-type glutamate receptors improved recovery after 90 minutes of aglycemia by 250%. Aglycemic injury was increased by reducing [Mg(2+)]o or increasing [glycine]o , and decreased by lowering pHo , expected results for NMDA receptor-mediated injury. pHo increased during aglycemia due to a drop in [lactate(-)]o. Aglycemic injury was dramatically reduced in the absence of [Ca(2+)]o. Extracellular aspartate, a selective NMDA receptor agonist, increased during aglycemia ([glutamate]o fell). Aglycemia injured WM by a unique excitotoxic mechanism involving NMDA receptors (located primarily on oligodendrocytes). During WM aglycemia, the selective NMDA agonist aspartate is released, probably from astrocytes. Injury is mediated by Ca(2+) influx through aspartate-activated NMDA receptors made permeable by an accompanying alkaline shift in pHo caused by a fall in [lactate(-)]o. These insights have important clinical implications.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Glycin, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Glycin, suitable for electrophoresis, ≥99%
Sigma-Aldrich
Glycin, BioUltra, for molecular biology, ≥99.0% (NT)
Sigma-Aldrich
L-Asparaginsäure, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
Kynurensäure, ≥98%
Sigma-Aldrich
Glycin, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, ≥98.5%
SAFC
Glycin
Sigma-Aldrich
Glycin -hydrochlorid, ≥99% (HPLC)
Sigma-Aldrich
L-Asparaginsäure, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
Glycogen aus Austern
Sigma-Aldrich
Glycogen aus Rinderleber, ≥85% dry basis (enzymatic)
USP
Glycin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
L-Asparaginsäure, BioXtra, ≥99% (HPLC)
Sigma-Aldrich
Glykogen aus Muscheln, Mytilus-Gattung aus Mytilus edulis (Miesmuschel), for DNA precipitations
Sigma-Aldrich
Glycin, BioXtra, ≥99% (titration)
Sigma-Aldrich
L-Asparaginsäure Kaliumsalz, ≥98% (HPLC)
Sigma-Aldrich
Glycin 1 M -Lösung
Sigma-Aldrich
DL-Asparaginsäure, ≥99% (TLC)
Sigma-Aldrich
L-Asparaginsäure, BioUltra, ≥99.5% (T)
Sigma-Aldrich
Glycogen aus Kaninchenleber, ≥85% dry basis (enzymatic)
Sigma-Aldrich
Glycin, 99%, FCC
SAFC
L-Asparaginsäure
Sigma-Aldrich
Glykogen aus Muscheln, Mytilus-Gattung aus Mytilus edulis (Miesmuschel), ≥85% anhydrous basis (enzymatic)
Sigma-Aldrich
Glycin, meets analytical specification of Ph. Eur., BP, USP, 99-101% (based on anhydrous substance)
Sigma-Aldrich
Glycin, ACS reagent, ≥98.5%
Sigma-Aldrich
NBQX Dinatriumsalz Hydrat, ≥98% (HPLC)
Supelco
Glycin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
(±)-AMPA, solid
Sigma-Aldrich
(S)-AMPA, ≥97%
Supelco
Glycin, analytical standard, for nitrogen determination according to Kjeldahl method